VON WILLEBRAND DISEASE (VWD)
Clinical trials for VON WILLEBRAND DISEASE (VWD) explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD) trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for controlling dangerous bleeds in rare blood disorder
Disease control Recruiting nowThis study is testing a new treatment called VONVENDI, sometimes given with another drug called ADVATE, to see if it safely and effectively controls bleeding episodes in Chinese adults with Von Willebrand Disease (VWD). The goal is to help people with VWD manage bleeding during s…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial aims to control bleeding disorder
Disease control Recruiting nowThis early-stage study is testing a new drug called HMB-002 in adults with Von Willebrand Disease, a genetic bleeding disorder. The main goals are to check if the drug is safe, determine the right dose, and see if it helps reduce bleeding episodes. Researchers will first test sin…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Lifeline extended: patients get continued access to promising blood disorder drug
Disease control AVAILABLEThis program allows children and adults with severe Von Willebrand Disease (VWD) to continue receiving an experimental treatment they benefited from in a previous study. It's for patients who have no other good treatment options available in their country and would be harmed if t…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for kids with rare bleeding disorder
Disease control Recruiting nowThis study is testing whether a lab-made clotting factor called vonicog alfa can safely prevent bleeding episodes in children with severe Von Willebrand Disease (VWD). It will enroll 24 children under 18 who have previously been treated for VWD. Participants will receive the trea…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New treatment monitored for safety in kids with rare bleeding disorder
Disease control Recruiting nowThis study is monitoring how safe and effective a treatment called vonicog alfa is for children under 18 with Von Willebrand Disease, a rare bleeding disorder. Doctors in Japan will observe about 13 children receiving this treatment during normal medical care for bleeding episode…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New injection could transform life for bleeding disorder patients
Disease control Recruiting nowThis study is testing whether a new injection called VGA039 can safely prevent bleeding episodes in people with von Willebrand disease, a genetic bleeding disorder. The trial will follow 60 patients aged 12-75 who experience frequent bleeding episodes. Participants will first be …
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Vega Therapeutics, Inc • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Scientists track bleeds in rare blood disorder
Knowledge-focused Recruiting nowThis study aims to collect detailed information about how often people with Von Willebrand Disease (VWD) experience bleeding, how it affects their lives, and what treatments they use. Researchers will follow about 200 participants for 4 to 12 months, checking in regularly to trac…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Hemab ApS • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC
-
Scientists probe cells to unlock secrets of bleeding disorder
Knowledge-focused Recruiting nowThis study aims to understand how von Willebrand disease (VWD) affects the body's blood vessel cells. Researchers will collect blood samples from 48 people—some with VWD, some with a related acquired condition, and some healthy volunteers—to grow and compare their cells in the la…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC